Cytokine receptors in Omentum-associated lymphoid tissue and Gut-associated lymphoid tissue

Cytokine receptors in Omentum-associated lymphoid tissue (OALT) and Gut-associated lymphoid tissue (GALT) represent a diverse group of cell-surface proteins that mediate immune signaling in the peritoneal and intestinal environments (Source: PubMed, PMID: 31435046). These receptors, including members of the tumor necrosis factor receptor (TNFR) and interleukin receptor families, are essential for coordinating local immune defenses and maintaining mucosal tolerance (Source: NIH, GALT Overview). In many inflammatory and autoimmune conditions, such as Crohn's disease and ulcerative colitis, overactive cytokine signaling within these lymphoid tissues drives chronic tissue destruction (Source: StatPearls, Inflammatory Bowel Disease). Pharmacological targeting of these receptors or their ligands—using biologics like TNF inhibitors (e.g., Infliximab) or IL-12/23 antagonists (e.g., Ustekinumab)—is a cornerstone of modern immunology (Source: PubChem, Infliximab). However, as a target definition, this term is considered incorrect because it is overly broad, encompassing numerous distinct proteins across different anatomical locations rather than a single, specific molecular target.

Other names

GALT cytokine receptorsOALT cytokine receptorsMucosal cytokine receptorsIntestinal cytokine receptors

Blockade of cytokine-mediated signaling pathways through the neutralization of ligands or competitive inhibition of their respective receptors to reduce mucosal and systemic inflammation (Source: PubMed, PMID: 29431075).